Prometheus Laboratories Inc.
San Diego, CA, United States
2
Total Recalls
0
Class I Recalls
0
Ongoing Recalls
Recalls by Prometheus Laboratories Inc.
FDA Drug
Class II
Terminated
Mercaptopurine Tablets, USP 50mg, a) 60-count bottle (NDC 49884-922-02), b) 250-count bottle (NDC 49884-922-04), RX only, Manufactured by Stason Pharmaceuticals, Inc., 11 Morgan, Irvine, CA 92618 for
October 22, 2014
Prometheus Laboratories Inc.
16,296 bottles (60-count), 5,166 bottles (250-count) units
FDA Drug
Class II
Terminated
Mercaptopurine Tablets, USP, 50 mg, packaged in a) 60-count tablets per bottle (NDC 49884-922-02) and b) 250-count tablets per bottle (NDC 49884-922-04), Rx only, Distributed by: Par Pharmaceutical Co
June 29, 2012
Prometheus Laboratories Inc.
a) 25,516 bottles; b) 2,569 bottles units